Floatz logo

ctx0e03 drug product and delivery device

Arm Paralysis

ReNeuron LimitedCell therapyPhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Arm Paralysis cohort.

Asset / SponsorPhaseRating
Ctx Dp
ReNeuron Limited
Phase 2B

Same molecule, other indications

ctx0e03 drug product and delivery device is also rated in:

stroke disorderDormant
CCC
Indicative ·
53 / 100
View asset →
hemiplegiaDormant
CCC
Indicative ·
53 / 100
View asset →
ischemic strokeDormant
CCC
Indicative ·
48 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →